Androgen Receptor Inhibitor drugs compared
Compare all 3 Androgen Receptor Inhibitor drugs side by side, used for conditions such as prostatic neoplasms. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is xtandi.
Top-rated androgen receptor inhibitor: 1. Xtandi · 2. Casodex · 3. Enzalutamide
| Drug | Generic | Form | Status | Used for | Safety ratingFDA recall-based | Pharmacy pays |
|---|---|---|---|---|---|---|
| Xtandi | Enzalutamide | Tablet | Prescription | Prostatic Neoplasms | 72/100 | — |
| Casodex | Bicalutamide | Tablet | Prescription | Prostatic Neoplasms | 70/100 | $12 |
| Enzalutamide | — | Tablet | Prescription | Prostatic Neoplasms | 68/100 | — |
The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.
Best androgen receptor inhibitor by condition
Full ranking · 3 drugs
Frequently asked questions
What is the Androgen Receptor Inhibitor drug class?
Androgen Receptor Inhibitor is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 3 Androgen Receptor Inhibitor products, each independently rated.
Are all Androgen Receptor Inhibitor drugs the same?
No. Androgen Receptor Inhibitor drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Androgen Receptor Inhibitor drugs treat?
Per NIH RxClass drug-classification data, Androgen Receptor Inhibitor drugs are used for conditions including prostatic neoplasms.
Which Androgen Receptor Inhibitor drug is best-rated?
By our independent rating, xtandi currently ranks highest among Androgen Receptor Inhibitor drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Sources: the Androgen Receptor Inhibitor class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.